Langenbeck S Archives of Surgery

NOV 3, 2026 · JOURNAL ARTICLE

Multivisceral pancreaticoduodenectomy with vascular resection: are aggressive surgical approaches justified for pancreatic head cancer?

Langenbeck S Archives of Surgery

The aim of this study was to evaluate the oncological justification for multivisceral pancreaticoduodenectomy with resection of the venous confluence (superior mesenteric and/or po

OCT 24, 2026 · JOURNAL ARTICLE

High prevalence of TROP2 expression identifies EBV-positive gastric cancer as a candidate for TROP2-directed antibody–drug conjugates

Langenbeck S Archives of Surgery

Abstract Purpose Trophoblast cell surface antigen 2 (TROP2) is a glycoprotein expressed on epithelial tumor cells and therefore an established target for antibody-drug conjugates (

OCT 8, 2026 · JOURNAL ARTICLE

Primary tumor resection versus systemic therapy alone in patients with colorectal cancer and unresectable distant metastases: a systematic review and meta-analysis

Langenbeck S Archives of Surgery

Abstract Background The role of primary tumor resection (PTR) in patients with colorectal cancer (CRC) and unresectable distant metastases remains controversial. While PTR may prev

OCT 5, 2026 · JOURNAL ARTICLE

Preoperative glycemic control and outcomes following metabolic and bariatric surgery in patients with type 2 diabetes

Langenbeck S Archives of Surgery

Abstract Background Metabolic and bariatric surgery (MBS) is an effective treatment for patients with obesity and type 2 diabetes (T2D). Preoperative T2D severity may influence per

SEP 26, 2026 · JOURNAL ARTICLE

Risk factors for recurrence after neoadjuvant docetaxel+cisplatin+5-fluorouracil (DCF) followed by surgery for esophageal squamous cell carcinoma: a single-institution retrospective analysis

Langenbeck S Archives of Surgery

The JCOG1109 trial proved the superiority of neoadjuvant chemotherapy (NAC) with docetaxel, cisplatin, and 5-fluorouracil (DCF) to chemotherapy with cisplatin and 5-fluorouracil (C

SEP 22, 2026 · JOURNAL ARTICLE

The impact of preoperative therapy with GLP-1 receptor agonists on weight loss and metabolic effects after bariatric surgeries – single-center preliminary study

Langenbeck S Archives of Surgery

Glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists) have become an integral component of obesity management. Although these agents effectively induce preoperative w

SEP 22, 2026 · JOURNAL ARTICLE

Upfront surgery vs. neoadjuvant therapy in pancreatic cancer with venous involvement: a multicenter retrospective analysis

Langenbeck S Archives of Surgery

Abstract Introduction The benefits of neoadjuvant therapy (NAT) for pancreatic cancer (PC) with portal venous involvement remain debated. This study aimed to compare the short- and

SEP 15, 2026 · JOURNAL ARTICLE

Long-term outcomes of the single-anastomosis sleeve jejunal bypass (SASJ): a single-center experience

Langenbeck S Archives of Surgery

Single-Anastomosis Sleeve Jejunal Bypass (SASJ) is an innovative metabolic bariatric surgery (MBS) designed to achieve meaningful weight loss with minimal nutritional risks. As a m